Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 29.00
Low: 28.50
Prev. Close: 28.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Signed agreement with Cirtec Medical

4 Aug 2023 07:00

RNS Number : 2707I
Ilika plc
04 August 2023
 

Ilika plc

("Ilika" or the "Company")

 

Signed licencing and royalty agreement with Cirtec Medical

 

Partnership to collaborate in the manufacturing and commercialisation of miniature Stereax solid-state batteries

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that, further to its announcement on 16 January 2023, it has concluded contractual negotiations with Cirtec Medical ('Cirtec'), an industry-leading strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, by signing a ten-year manufacturing licence for the production of the Stereax range of mm-scale batteries at Cirtec's facility in Lowell, Massachusetts, U.S.

 

Headlines of the contractual relationship include:

 

· A ten-year licence to manufacture the Stereax range of products

· Exclusivity for Cirtec in the field of medical devices designed to drive full utilisation of Cirtec's installed capacity

· Profit sharing during the initial period followed by royalty-bearing manufacturing aligned with industry norms, calculated on individual battery volumes

· Ilika to retain the cathode deposition process and back-end battery formation at their FAB facility in the UK as a sub-contract service to Cirtec

· Ilika to transfer some machine sets to the U.S. for Cirtec to operate on loan, to enable a quicker technology transfer and qualification process

 

Ilika will now focus on advanced technology development and IP licensing in support of Cirtec's manufacturing and commercialisation activities. This partnership will reinforce Cirtec's ongoing activities in system level miniaturisation for the medical device industry.

 

Ilika and Cirtec will now commence the technology transfer and certification process which will continue throughout the second half of 2023. The Cirtec commercial team will engage further with the Stereax customer list developed by Ilika and within their own customer base to expand the commercial opportunities now that the contractual terms of the agreement have been agreed.

 

Ilika's revenue guidance for the next few years remains unchanged for now and the Company will provide an update on commercial progress at its half year results in January 2024.

 

Graeme Purdy, Ilika's Chief Executive Officer, said: "We are delighted to be working with Cirtec for the commercialisation of Stereax. Cirtec has a very strong track record in the commercialisation of miniature medical devices and we believe this partnership is well-positioned to ensure a high quality, reliable and scalable supply of Stereax batteries to our customers."

 

Brian Highley, Cirtec Medical Chief Executive Officer, commented: "We are excited by the prospect of adding Stereax battery technology to our portfolio of medical device solutions. Our 20 years of experience in the design, development and manufacture of medical devices positions Cirtec strongly to work with Ilika to bring its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets."

 

For more information contact:

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Jason Stewart, Chief Financial Officer

Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber,

Nikhil Varghese

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,

Mara Grasso

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Lianne Applegarth

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

 

About Ilika Technologies 

Ilika specializes in the development of solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs. For more information about Ilika, please visit: https://www.ilika.com.

 

About Cirtec Medical

Cirtec Medical is a vertically integrated, full-service outsource partner providing end-to-end product design, development and manufacturing of Class III and II medical devices and components. Cirtec specialize in today's most advanced product technologies including, neuromodulation, implantable drug delivery, cardiac rhythm management, ventricular assist and minimally invasive systems including TAVR/TMVR. Cirtec has a global footprint with facilities in Brooklyn Park, MN; Chandler, AZ; Enfield, CT; San Jose CA, Lowell, MA, Coyal Free Zone, Costa Rica and Birkenfeld, Germany.

 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREXLFBXVLZBBE
Date   Source Headline
14th Oct 20197:00 amRNSLSE - Green Economy Classification & Mark
8th Oct 20197:00 amRNSBattery Patent Update
1st Oct 20191:34 pmRNSChange of registered address
26th Sep 20191:05 pmRNSResult of AGM
24th Sep 20197:00 amRNSIlika Opens Large Format Battery Facility
13th Sep 20197:00 amRNSBonus Share Options, Exercise of Options & TVR
10th Sep 20197:00 amRNSGrant Support from Faraday Battery Challenge
2nd Sep 20197:00 amRNSPosting of AR, Notice of AGM & Directorate Change
11th Jul 20197:00 amRNSFinal Results
26th Jun 20196:09 pmRNSHolding(s) in Company
26th Jun 20197:00 amRNSHigh Energy Density Miniature SolidState Batteries
12th Jun 20197:00 amRNSNotice of Results
29th May 20197:00 amRNSCustom Cell Capability
10th Apr 20197:00 amRNSSolid-state batteries in the MedTech space
26th Mar 20197:00 amRNSEnhanced Specifications of Solid-State Batteries
7th Mar 20197:00 amRNSDeployment of Wireless Sensors with Network Rail
5th Mar 20193:32 pmRNSHolding(s) in Company
12th Feb 201911:06 amRNSSecond Price Monitoring Extn
12th Feb 201911:01 amRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSStereax batteries yield record energy density
29th Jan 20197:00 amRNSGoliath Deployment Project
25th Jan 20194:41 pmRNSSecond Price Monitoring Extn
25th Jan 20194:35 pmRNSPrice Monitoring Extension
24th Jan 20197:00 amRNSGrant of Long Term Incentive Plan
17th Jan 20197:00 amRNSHalf-year Report
16th Jan 20197:00 amRNSDirectorate Change
8th Jan 20197:00 amRNSAutonomous Sensor Deployment Project
11th Dec 20187:00 amRNSISO9001: 2015 Recertification
10th Dec 20187:01 amRNSHolding(s) in Company
10th Dec 20187:01 amRNSHolding(s) in Company
6th Dec 20187:00 amRNSNotice of Results
29th Nov 20187:00 amRNSDirectorate Change
20th Nov 20187:00 amRNSManufacturing Partnership
7th Nov 20187:00 amRNSRecord Energy Density Achieved for Stereax
1st Nov 20187:00 amRNSHigher Power Cell Performance
18th Oct 20187:00 amRNSAutomotive Partner Sample Shipment
8th Oct 20187:00 amRNSCommencement of PowerDrive Line Collaboration
4th Oct 20183:21 pmRNSResult of AGM
4th Oct 20187:00 amRNSAGM Statement
2nd Oct 20187:00 amRNSPre-launch samples of mm-scale batteries shipped
27th Sep 20187:00 amRNSCEO to participate in panel discussion
10th Sep 20187:00 amRNSPosting of Annual Report and Notice of AGM
5th Sep 20187:00 amRNSDirectorate changes
31st Jul 20182:22 pmRNSHolding(s) in Company
31st Jul 20182:04 pmRNSHolding(s) in Company
30th Jul 20184:17 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSDirector/PDMR Shareholding
27th Jul 201811:21 amRNSResults of General Meeting and Open Offer
11th Jul 20186:04 pmRNSPosting of Open Offer Circular
11th Jul 20181:19 pmRNSResult of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.